Considering that SOX2 is considered the important CSC marker to promote tumor initiation and participate in tumor metastasis [23, 24], we presumed that METTL3 promoted CRC stemness and metastasis in an m6A-dependent manner to maintain SOX2 expression. The gene discussed is SOX2; the disease is colorectal carcinoma.